From: "Jeffrey E." <[email protected]> To: george church Subject: Re: $200K Date: Thu, 25 Sep 2014 11:22:41 +0000 On Thu, Sep 25, 2014 at 7:20 AM, george church < wrote: Sure. What hone number for you should I use? --george From: "Jeffrey E." <[email protected]> Date: Thursday, September 25, 2014 at 6:51 AM To: george church < > Subject: Re: $200K im avaible same ,„ woudl you like to initiate? On Thu, Sep 25, 2014 at 6:21 AM, george church c wrote: Yes. I'm free from 3:20 AM Palo Alto time (now) until 7:20 AM PT. -George From: "jeffrey E." <[email protected]> Date: Thursday, September 25, 2014 at 5:49 AM To: george church Richard Kahn Subject: Re: $200K can we do our calls today On The, Sep 9, 2014 at 8:49 AM, george church c wrote: Sure ... at --geo From: "jeffrey E." <[email protected]> Date: Tuesday, September 9, 2014 at 7:41 AM To: george church < > Subject: Re: $200K free to speak today>? On Sat, Sep 6, 2014 at 9:11 AM, george church a wrote: The Androcyte business plan is to patent products based on genomic (and epi-genomic) variants which are unique to one or more supercentenarians (SC). Each such DNA variant can be used to design and manufacture variant-specific RNAi molecules, proteins, and CRISPR guide-RNAs. The CRISPR is used for changing DNA in human cells (stem cells, neurons, etc) to match the SC variant or reversible activation or inhibition of the SC-impacted gene. Since we (Androcyte) have (by far) the most SC resources (including genomic variants already undergoing computational analyses) and have co-invented the CRISPR technology, we are in unique position to develop these therapies swiftly. These products will be tested in animals and in partnerships with pharmaceutical and skin care companies. Pharmaceuticals are becoming more costly due to increasingly smaller (personalized) markets (e.g. Glybera at $1.6M per treatment) -- Hence the prospect of Androcyte therapies that apply to every person